Obsidian Therapeutics, Inc. (OBX)
NASDAQ · Manufacturing · Pharmaceutical preparations
OBX price, last 12 months
Key stats
- Previous close
- $13.41
- Open
- $13.54
- Day range
- $12.16 – $13.70
- 52-week range
- $12.16 – $49.97
- Volume
- 431.9K
- Avg volume (20 days)
- 663K
- Market cap
- $794.4M
Performance
Technicals and fundamentals
About Obsidian Therapeutics, Inc.
Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $794.4M